Lessons From Vaccines - Two Viruses - Many Questions | Glenda E. Gray

AIDSImpact 2021 | Webinar Series

Long Acting Pre Exposure Prophylaxis for MSM and TGW Challenges & Opportunities - Beatriz Grinsztejn, MD, PhD

International Workshop on Innovations in Delivery of HIV Care 2021

Long acting HIV drugs for prevention: what are the data?- Pep Coll, MD

European Meeting on HIV & Hepatitis 2018

Special considerations before / during / after DAA therapy- Kosh Agarwal, MD

International Workshop on HIV & Hepatitis Co-infection 2017

French National survey of resistance to integrase inhibitors shows high differences of resistance selection rate in case of virological failure in a context of routine hospital care (ANRS AC11 virology network) - Vincent Calvez

European HIV Clinical Forum 2016

Prospects for Cure | Patrick Kennedy

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Abstract: Food intervention to make therapy with pazopanib more patient friendly and affordable (#06) | Floor Lubberman

International Workshop on Clinical Pharmacology of Anticancer Drugs (ICPAD) 2018

O_16: A mathematical model that predicts virological failure and elucidates the impact of lymph node drug penetration- Steven Sanche

International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2017

Isolation and Proteomic Profiling of Translocating Bacteria in Progressive SIV Infection of Rhesus Macaques

International Workshop on Microbiome and HIV Pathogenesis, Prevention, and Treatment 2021

High incidence of severe Respiratory Syncytial Virus’ infection among HIV-exposed uninfected infants

International Workshop on HIV Pediatrics 2021